Dr Joseph Alvarnas: Cancer Care Equity Act Meets the Needs of Patients With Advanced Disease
November 12th 2022Joseph Alvarnas, MD, vice president of government affairs at City of Hope and chief clinical adviser of AccessHope in Duarte, California, spoke on how the California Cancer Care Equity Act will allow oncologists to escalate the care of patients with advanced cancers toward established centers that can better meet their needs, as well as implications from the decision to exclude genomic testing coverage in the bill.
Watch
Dr Melissa O'Connor: Further Research Needed for Technology Use in Home Health
November 12th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in community and home health nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, spoke on the early use of technology in assessing older adults in the home setting and what research is required to improve best practices for their use.
Watch
Dr Amresh Raina Addresses Gender Differences in HF Presentation
November 12th 2022Disease symptomatology may be the same, but the presentation of heart failure (HF) and heart attacks differ between women and men, explained Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Watch
CDI-Related Mortality Risk Greater in Hospitalized Children With Cystic Fibrosis
November 11th 2022Pediatric patients who developed coexisting Clostridioides difficile infection (CDI) while hospitalized for cystic fibrosis exhibited greater mortality risk, length of stay, and cost compared with those without cooccuring CDI.
Read More
Dr Liz Lightstone on Emerging Treatment Options, Unmet Needs in Lupus Nephritis
November 11th 2022Liz Lightstone, MBBS, PhD, FRCP, professor of renal medicine for the faculty of medicine, Imperial College London, discussed recently approved therapeutic options for patients with lupus nephritis and what unmet needs persist in the management of the disease.
Watch
Dr Joseph Alvarnas Explains Barriers to Clinical Trial Diversity and Payer Participation
November 11th 2022For the US health care system to be appropriately patient-centered, clinical trials need to be reflective of the country's diversity, said Joseph Alvarnas, MD, vice president of government affairs and senior medical director for employer strategy at City of Hope.
Watch
Dr Debra Patt: DESTINY-Breast04 Realizes a Promise of Modern Cancer Therapy
November 11th 2022Debra Patt, MD, PhD, MBA, executive vice president of public policy and strategic initiatives at Texas Oncology, expands on her keynote address at the 2022 meeting of Patient-Centered Oncology Care®, which focused on DESTINY-Breast04 study findings and their applicability to managed care.
Watch
Social Impact of Hidradenitis Suppurativa Associated With Worse QOL, Mental Health Burden
November 11th 2022Patients with hidradenitis suppurativa who reported feelings of stigmatization due to their condition had worse quality of life and higher levels of depression and social anxiety vs those not reporting feelings of stigmatization.
Read More
More than 100 health care organizations signed a HHS climate resilience pledge; linking patients in addiction treatment with a primary care practitioner is linked with improved long-term health outcomes; older men and women with weak grip strength may have accelerated biological aging.
Read More
Study Finds Persistent Use of e-Cigarettes Among Middle, High School Students
November 11th 2022The report, from the CDC, said that more than 3 million youth, or almost 1 in 9, reported using tobacco this year, and that disparities persist among US middle and high school students, with the highest rates among those who struggle in school or who have severe severe psychological distress.
Read More
NSAIDs May Be Safe for Use in Hemophilia, but More Research Is Needed
November 11th 2022The hesitation to prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to patients with hemophilia is not supported by current research, based on a recently published review, but the available studies had significant limitations.
Read More
Meet Dr Ishani Ganguli, Seema S. Sonnad Emerging Leader in Managed Care Research Award Recipient
November 10th 2022Ishani Ganguli, MD, MPH, assistant professor of medicine at Harvard Medical School, physician at Brigham and Women’s Hospital, reacts to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Watch
Simvastatin Ineffective as Disease-Modifying Therapy for Intermediate Parkinson Disease
November 10th 2022Patients with intermediate and mild Parkinson disease, defined by a Hoehn & Yahr stage of 3 or less, experienced an additional deterioration in motor function with simvastatin compared with placebo while not taking medication at 24 months.
Read More
Dr Neil Iyengar Emphasizes Importance of Population Health Lens in Oncology at PCOC 2022
November 10th 2022Population health brings an important lens to both oncology practice and research, said Neil Iyengar, MD, associate attending physician, breast medical service, Memorial Sloan Kettering Cancer Center.
Watch
What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial
November 10th 2022A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.
Read More
Comorbid Septic Shock, HFrEF Linked to Lack of Guideline-Recommended Treatment
November 10th 2022Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated with fluids—more data are needed on outcomes following fluid administration.
Read More
Investigating Real-World Effectiveness of Disease-Modifying Therapies in AD by Skin Type
November 10th 2022Real-world patients with atopic dermatitis with dark skin types showed greater mean reduction in disease severity between baseline and 6 months with dupilumab compared with those with light skin types, whereas no differences were observed regarding severity reduction for methotrexate and ciclosporin.
Read More